Tervis
1080 instrumentiTervishoiusektoris tegutsevad ettevõtted
Eli Lilly$LLY·Health | 1,1 trln $ | 0,59% | 41,885 | 0,481 |
|---|---|---|---|---|
Johnson & Johnson$JNJ·Health | 609 mld $ | 2,12% | 29,332 | 0,235 |
AbbVie$ABBV·Health | 450 mld $ | 2,72% | 125,361 | 0,305 |
UnitedHealth$UNH·Health | 387 mld $ | 2,18% | 27,43 | 0 |
Roche HoldingFr. ROP·Health | 266 mld CHF | 2,94% | 20,779 | 0,33 |
Roche Holding€ROP·Health | 286 mld € | 0,00% | 20,636 | 0,33 |
Merck & Co.$MRK·Health | 315 mld $ | 2,67% | 35,656 | 0,218 |
Novartis$NVS·Health | 283 mld $ | 2,00% | 22,026 | 0,487 |
Novartis AG€NOVN·Health | 248 mld € | 3,03% | 22,102 | 0,487 |
Novartis AGFr. NOVN·Health | 229 mld CHF | 2,97% | 22,078 | 0,487 |
AstraZeneca$AZN·Health | 263 mld $ | 2,57% | 25,437 | 0,223 |
AstraZeneca£AZN·Health | 195 mld £ | 1,87% | 25,566 | 0,223 |
Novo Nordisk$NVO·Health | 223 mld $ | 3,47% | 11,998 | 0,348 |
Novo NordiskDKr NOVO B·Health | 1,5 trln kr | 3,55% | 12,012 | 0,348 |
Novo Nordisk€NOVOB·Health | 195 mld € | 3,57% | 11,986 | 0,348 |
Thermo Fisher Scientific$TMO·Health | 198 mld $ | 0,35% | 29,268 | 0,883 |
Amgen$AMGN·Health | 198 mld $ | 2,75% | 25,493 | 0,435 |
Abbott$ABT·Health | 175 mld $ | 2,50% | 32,617 | 0,607 |
Gilead Sciences$GILD·Health | 167 mld $ | 2,44% | 18,263 | 0,332 |
Danaher$DHR·Health | 144 mld $ | 0,78% | 39,362 | 0,823 |